Hepatitis C Hepatitis C  Bradley at the Centers for Disease Control and Prevention, used a novel molecular cloning approach to identify the unknown organism and develop a diagnostic test.  In 1988, Alter confirmed the virus by verifying its presence in a panel of NANBH specimens, and Chiron announced its discovery at a Washington, DC Press conference in May, 1988. At the time, Chiron was in talks with the Japanese health ministry to sell a biotech version of the Hepatitis B vaccine.  Simultaneously, Emperor Hirohito had developed cancer and required numerous blood transfusions.  The Japanese health ministry placed a screening order for Chiron's experimental NANBH test.  Chiron's Japanese marketing subsidiary, Diagnostic Systems KK, introduced the term "Hepatitis C" in November, 1988 in Tokyo news reports publicizing the testing of the emperor's blood.  Chiron sold a screening order to the Japanese health ministry in November 1988, earning the company US$60 million a year Hepatitis C Hepatitis C